Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",21833,195,1.10 [0.78-1.54],0.587601677443544
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23046,252,1.18 [0.88-1.58],0.2772117395832449
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22771,1752,1.14 [1.02-1.28],0.0222439567437207
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Candidiasis,23052,551,1.19 [0.98-1.46],0.0801918427824757
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22294,4233,1.11 [1.03-1.19],0.0054732825012403
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22240,4315,1.15 [1.07-1.23],0.0001540403138316
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22756,1428,1.11 [0.98-1.26],0.09291670241028
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,22953,130,1.21 [0.81-1.82],0.3561083672825492
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20228,1302,1.17 [1.03-1.34],0.0153180504532988
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19517,1585,1.31 [1.17-1.47],3.119660782517624e-06
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,19010,341,1.12 [0.87-1.44],0.39359541049085
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14976,2750,1.26 [1.15-1.38],3.822105024001529e-07
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18944,495,1.25 [1.02-1.54],0.0345303989800667
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23028,1700,1.14 [1.01-1.28],0.0295047564959126
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Mycoses,23147,646,1.15 [0.96-1.39],0.1279363069884738
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22263,1244,1.24 [1.09-1.41],0.001382179686364
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23075,1437,1.13 [1.00-1.28],0.05393986927258
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21580,252,1.19 [0.88-1.59],0.257314272497282
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23207,67,0.69 [0.37-1.26],0.2252873592055276
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22892,1254,1.14 [1.00-1.30],0.0520558205901955
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22904,81,1.32 [0.80-2.19],0.2754316226663141
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23142,144,1.39 [0.96-2.03],0.0827732945530619
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23120,122,1.32 [0.87-2.00],0.1854679808932944
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21515,496,1.07 [0.87-1.33],0.5138505377076634
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21326,307,1.19 [0.92-1.55],0.1934330242697091
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21467,139,1.20 [0.81-1.79],0.3623525427610444
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23192,51,0.97 [0.50-1.89],0.9238314569037398
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23138,176,1.08 [0.75-1.55],0.6853360099376321
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Viral warts,23018,56,1.21 [0.64-2.28],0.5521551972266623
APOH,Beta-2-glycoprotein 1,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23043,81,1.04 [0.61-1.78],0.8822155929070291
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Benign lipomatous neoplasm,22913,267,1.04 [0.77-1.39],0.8152167256076102
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23124,39,1.00 [0.46-2.19],0.9955657346051384
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23107,44,1.37 [0.70-2.71],0.3568668789694764
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,11060,86,1.21 [0.73-2.00],0.4663808188505676
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22740,1680,1.13 [1.01-1.27],0.0331267990237462
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Benign neoplasm of meninges,23191,64,1.06 [0.58-1.95],0.8518736756406333
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23111,78,1.87 [1.18-2.95],0.0077262709792813
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23179,120,1.36 [0.90-2.06],0.1455867484374771
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Benign neoplasm of ovary,12076,80,0.52 [0.29-0.93],0.0282760532184849
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23168,446,1.27 [1.02-1.58],0.0308868005473554
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Benign neoplasm: Caecum,23173,387,1.10 [0.87-1.40],0.4323715141730114
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23058,86,0.84 [0.49-1.41],0.5026632287176558
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Benign neoplasm: Descending colon,23163,255,1.01 [0.75-1.36],0.9500106768247116
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Benign neoplasm: Rectum,23122,406,1.17 [0.92-1.47],0.1983847740591701
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23050,680,1.09 [0.91-1.30],0.3670930824233709
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23150,541,1.03 [0.84-1.26],0.786104800339595
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Carcinoma in situ of breast,9075,49,0.91 [0.44-1.89],0.8062529200333103
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",9118,65,1.25 [0.69-2.25],0.4662487390048145
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16551,73,0.81 [0.45-1.46],0.4916724855178638
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16578,100,0.79 [0.48-1.30],0.3505743077633876
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23150,126,1.14 [0.75-1.75],0.5387585965328302
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Haemangioma, any site",23151,123,1.13 [0.73-1.74],0.5937891476184256
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Leiomyoma of uterus,11808,165,1.15 [0.79-1.68],0.4736498426892772
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Lung cancer and mesothelioma,14669,483,0.99 [0.80-1.23],0.937429647158384
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Lymphoid leukaemia,16552,74,0.69 [0.38-1.24],0.2121285505144925
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16701,223,1.19 [0.87-1.63],0.28145418322696
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16799,321,0.94 [0.72-1.23],0.6634667284244715
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",9199,105,0.93 [0.57-1.52],0.7809824464814551
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16588,110,1.27 [0.82-1.97],0.2800410822816005
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16620,142,1.00 [0.67-1.48],0.9859601724085596
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16602,124,0.90 [0.58-1.38],0.6310659739041959
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",9182,88,1.05 [0.63-1.78],0.8406348069090931
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16607,129,1.28 [0.85-1.92],0.2323309836586979
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8360,976,1.06 [0.91-1.24],0.4588881562964919
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16615,137,1.11 [0.74-1.66],0.6291661583852995
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16569,91,0.85 [0.51-1.41],0.5342558396124878
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16623,145,1.56 [1.08-2.23],0.0165828123563318
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Melanocytic naevi,23061,184,1.02 [0.71-1.46],0.918395254932008
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Melanocytic naevi of trunk,23179,76,1.25 [0.73-2.13],0.4179479665518459
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Melanoma in situ,16531,111,1.00 [0.63-1.60],0.9844230981424548
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16601,123,0.78 [0.50-1.22],0.2737916772995542
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16682,204,0.75 [0.53-1.07],0.1125468735262715
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16807,329,1.04 [0.80-1.35],0.7609064304811386
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16608,130,0.73 [0.47-1.13],0.1553666423712141
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,Other benign neoplasms of skin,23033,164,1.02 [0.70-1.49],0.9045155600289416
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",17972,1494,1.05 [0.93-1.19],0.4341147184389923
APOH,Beta-2-glycoprotein 1,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",18057,1579,1.06 [0.94-1.20],0.3662621253533501
APOH,Beta-2-glycoprotein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22896,395,0.88 [0.69-1.13],0.3233825769404526
APOH,Beta-2-glycoprotein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,20875,163,2.19 [1.61-2.96],4.5878865767180893e-07
APOH,Beta-2-glycoprotein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22572,71,1.36 [0.79-2.35],0.260552339879133
APOH,Beta-2-glycoprotein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22443,3526,1.17 [1.08-1.26],0.0001701783335983
APOH,Beta-2-glycoprotein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21473,74,1.42 [0.85-2.38],0.1764704107785786
APOH,Beta-2-glycoprotein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22733,66,0.66 [0.36-1.21],0.1804689542111984
APOH,Beta-2-glycoprotein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22692,1980,1.20 [1.08-1.33],0.0006785686293651
APOH,Beta-2-glycoprotein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22690,1978,1.19 [1.07-1.33],0.0009752709222591
APOH,Beta-2-glycoprotein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,20828,116,1.27 [0.83-1.96],0.2750924580794049
APOH,Beta-2-glycoprotein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22843,1444,1.31 [1.16-1.48],1.1405015188896712e-05
APOH,Beta-2-glycoprotein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22782,115,0.92 [0.58-1.46],0.7311268902420931
APOH,Beta-2-glycoprotein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22577,76,1.09 [0.63-1.87],0.7670430460665966
APOH,Beta-2-glycoprotein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22577,76,1.54 [0.93-2.54],0.0911431945097787
APOH,Beta-2-glycoprotein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23026,359,1.03 [0.80-1.33],0.8163243881326373
APOH,Beta-2-glycoprotein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23076,41,0.75 [0.34-1.65],0.4768747186247023
APOH,Beta-2-glycoprotein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",22962,295,1.07 [0.81-1.41],0.6201081269887538
APOH,Beta-2-glycoprotein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21536,137,1.60 [1.10-2.32],0.0143103706022992
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15488,419,1.45 [1.17-1.81],0.0007909491245774
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21688,103,0.77 [0.50-1.19],0.2461793739743021
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21699,114,1.10 [0.71-1.71],0.658282762865241
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,15140,71,0.95 [0.52-1.71],0.855197272410517
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21553,65,0.66 [0.35-1.21],0.1774638966015724
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,20763,318,1.21 [0.93-1.56],0.1488657952324424
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22408,961,1.28 [1.11-1.49],0.0008531413374727
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,21931,484,1.10 [0.88-1.36],0.3955509425432539
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21666,219,1.15 [0.84-1.58],0.3916043846729089
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,22920,1432,1.21 [1.07-1.37],0.0027094037568086
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19517,1387,1.23 [1.08-1.40],0.0013157597110159
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",15163,94,1.49 [0.94-2.37],0.0896888398922345
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20898,102,1.02 [0.63-1.65],0.9352822077688216
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15440,371,1.28 [1.00-1.63],0.0480071680313274
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,15125,56,0.83 [0.42-1.64],0.5933784772748729
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19706,4637,1.12 [1.04-1.20],0.0019196271247282
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15335,266,1.40 [1.06-1.86],0.016585312943548
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15784,715,1.26 [1.06-1.51],0.0087241585631454
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23146,371,1.75 [1.41-2.17],3.2647836568985497e-07
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,22938,163,2.19 [1.64-2.93],1.1018550429363757e-07
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,15224,155,0.92 [0.61-1.37],0.6667191775501707
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",15151,82,1.14 [0.66-1.95],0.6387007577250672
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22562,1766,1.09 [0.97-1.22],0.1408661590067249
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15458,389,1.40 [1.11-1.77],0.0041102306171197
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15497,428,1.80 [1.47-2.20],1.3887260823131298e-08
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15936,867,1.31 [1.11-1.53],0.0009789144398848
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,15248,179,1.40 [1.00-1.97],0.0516928544462696
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,22928,153,2.17 [1.61-2.94],4.246433263825814e-07
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15968,899,1.37 [1.18-1.60],4.990936694868803e-05
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15730,661,1.17 [0.97-1.42],0.0929756563167843
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20524,79,1.16 [0.69-1.97],0.5697240633378305
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21555,6486,1.14 [1.08-1.21],1.5046634700064503e-05
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20857,61,1.13 [0.61-2.09],0.6977744911690065
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20847,51,1.33 [0.69-2.56],0.390291968806599
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23020,1913,1.09 [0.97-1.21],0.1336024057876229
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23018,1911,1.09 [0.98-1.21],0.1211328114563669
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20862,66,1.79 [1.08-2.96],0.0232387023148079
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,22853,1139,1.05 [0.91-1.21],0.5246473591759611
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17323,2254,1.34 [1.22-1.48],3.4955249378279007e-09
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23191,317,1.37 [1.07-1.75],0.0119731005132064
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21578,131,1.16 [0.77-1.73],0.4770236136924397
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21831,117,0.81 [0.51-1.28],0.3738034011348961
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21879,165,1.10 [0.75-1.60],0.6275536932008783
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",15272,203,1.53 [1.12-2.10],0.0080589327617997
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20394,186,1.19 [0.85-1.67],0.3202275280255024
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2490,100,1.63 [1.10-2.42],0.0160059386157975
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2661,313,1.16 [0.90-1.48],0.2451312944746084
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20294,86,1.20 [0.74-1.96],0.4661819474315836
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2463,76,1.91 [1.27-2.87],0.0017828227180745
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22355,2147,1.18 [1.07-1.30],0.0014014318837142
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22079,632,1.09 [0.90-1.31],0.3923566820469698
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,20897,452,1.01 [0.80-1.26],0.9527383712692514
APOH,Beta-2-glycoprotein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,16192,1123,1.49 [1.30-1.70],6.089811153116521e-09
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23070,303,1.21 [0.93-1.59],0.1556976542674849
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21699,269,1.21 [0.92-1.60],0.1712019284407682
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Angina pectoris,20031,1576,1.19 [1.05-1.34],0.0045036764145542
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Aortic aneurysm,21806,376,1.17 [0.92-1.49],0.1912991594230079
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21519,89,0.99 [0.60-1.64],0.9746949780119764
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21723,293,1.08 [0.82-1.42],0.5897516124076055
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11738,2856,1.10 [1.01-1.21],0.0342647568843042
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,AV-block,17611,674,1.15 [0.96-1.38],0.1326157355184501
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23125,579,1.03 [0.85-1.26],0.755069337517063
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Cardiac arrest,9147,265,1.48 [1.13-1.95],0.00493903485083
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Cardiomyopathy,17140,203,1.36 [0.99-1.87],0.0599181671476277
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",17046,109,1.43 [0.93-2.19],0.1034632006727713
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23202,78,1.11 [0.66-1.87],0.7025291550829764
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Conduction disorders,18499,1562,1.13 [1.00-1.28],0.0415116704105477
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21198,2768,1.13 [1.03-1.23],0.0101283845824247
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18617,8935,1.11 [1.06-1.17],4.0562140861421054e-05
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21619,334,1.23 [0.95-1.58],0.1150170195558974
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Endocarditis,17040,103,1.38 [0.88-2.17],0.1606461460600221
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22913,1677,1.19 [1.07-1.34],0.0019907748458696
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Hypertension,19863,7953,1.14 [1.08-1.20],2.3597862167219552e-06
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19884,7974,1.14 [1.08-1.21],1.3496360688129188e-06
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23034,96,1.41 [0.90-2.21],0.1348624635290736
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12174,264,1.20 [0.90-1.60],0.2237121843389233
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12115,205,2.73 [2.14-3.47],4.513437044153534e-16
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Hypotension,23024,1651,1.11 [0.99-1.24],0.0880251411812475
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,21902,149,1.03 [0.69-1.53],0.8918447449659471
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21370,2915,1.13 [1.04-1.24],0.0059882848151138
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22689,808,1.06 [0.90-1.26],0.4683187787607803
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17465,528,1.27 [1.04-1.56],0.019095869185179
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22505,1070,1.07 [0.92-1.23],0.3850970439051295
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19377,922,1.08 [0.92-1.27],0.3299369984400452
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23075,189,0.91 [0.64-1.29],0.5950574669785251
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23162,414,1.16 [0.92-1.45],0.2178652351460396
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Oesophageal varices,21353,68,1.31 [0.75-2.29],0.3366953976298897
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Other aneurysm,21534,104,1.29 [0.82-2.02],0.2736490651008705
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Other arrhythmias,17536,599,1.04 [0.85-1.27],0.7106263308842928
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21567,137,0.95 [0.63-1.43],0.8050555892384174
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21765,335,1.05 [0.81-1.36],0.7216981045117385
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,17160,223,0.99 [0.71-1.37],0.9557928669297882
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Other disorders of veins,21407,122,1.37 [0.91-2.05],0.1271184599309176
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21330,45,1.10 [0.55-2.21],0.7819142286990426
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21128,90,0.73 [0.44-1.23],0.2429639675587618
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21468,183,1.29 [0.92-1.82],0.1388519737144189
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18413,1476,1.03 [0.91-1.17],0.6365305604632692
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21436,63,1.25 [0.71-2.22],0.4349734580450793
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22161,731,1.06 [0.89-1.26],0.5336538084978656
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22429,529,1.07 [0.88-1.32],0.4932224548415137
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22025,987,1.16 [1.00-1.35],0.0531040315256453
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9302,420,1.21 [0.95-1.53],0.1173733518782609
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21990,595,1.10 [0.91-1.33],0.3288545347733059
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21707,422,1.13 [0.89-1.42],0.3089152572733449
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22506,606,1.06 [0.88-1.29],0.5372534063929733
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23105,983,1.09 [0.94-1.27],0.2566527463631433
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17456,519,1.06 [0.86-1.31],0.5742972377886102
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22422,522,1.08 [0.88-1.32],0.4795676837974295
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21306,268,1.44 [1.10-1.89],0.0085115147959536
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22673,920,1.04 [0.89-1.22],0.6297363336845052
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22658,961,1.05 [0.90-1.22],0.5456864661355374
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,21870,63,1.17 [0.64-2.12],0.6162507644999133
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21537,107,1.42 [0.92-2.20],0.1167644223799986
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22206,325,1.11 [0.85-1.44],0.4445209442868773
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21770,335,1.18 [0.92-1.53],0.1926165780135489
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Varicose veins,21809,524,0.93 [0.75-1.15],0.4904518368289946
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21447,120,1.57 [1.05-2.34],0.0281082022746687
APOH,Beta-2-glycoprotein 1,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22928,952,1.07 [0.92-1.25],0.3625175069536127
APOH,Beta-2-glycoprotein 1,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23125,336,1.13 [0.88-1.46],0.3442943831902343
APOH,Beta-2-glycoprotein 1,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19810,1385,1.04 [0.91-1.18],0.5706386625174547
APOH,Beta-2-glycoprotein 1,Chapter V Mental and behavioural disorders,Any mental disorder,22670,4245,1.08 [1.00-1.16],0.0494802318230277
APOH,Beta-2-glycoprotein 1,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23096,396,1.06 [0.84-1.34],0.6262682609805384
APOH,Beta-2-glycoprotein 1,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19884,1459,1.19 [1.05-1.34],0.0064779849943958
APOH,Beta-2-glycoprotein 1,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18512,87,1.05 [0.63-1.75],0.8490608008494764
APOH,Beta-2-glycoprotein 1,Chapter V Mental and behavioural disorders,Smoking dependency,22687,1189,1.01 [0.88-1.16],0.8838166548759852
APOH,Beta-2-glycoprotein 1,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19888,1463,1.03 [0.91-1.17],0.6565281405658223
APOH,Beta-2-glycoprotein 1,Chapter V Mental and behavioural disorders,Vascular dementia,22297,231,1.09 [0.80-1.49],0.5767785632055831
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Alzheimer disease,23204,594,1.10 [0.90-1.34],0.3431334092100992
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",14192,111,1.58 [1.03-2.43],0.0370721592042449
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Bell's palsy,21347,84,1.28 [0.77-2.12],0.3470275070395996
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21753,490,1.20 [0.97-1.48],0.0950868260805113
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Cerebral cysts,22749,250,1.02 [0.75-1.38],0.8913874386254179
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23129,417,1.01 [0.80-1.27],0.9662876383725728
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22347,76,1.19 [0.70-2.05],0.5226326394285807
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23185,68,1.28 [0.73-2.22],0.3895036192213261
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22586,87,0.73 [0.43-1.24],0.2482767966825885
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Epilepsy,21684,306,1.32 [1.01-1.71],0.0402132502706928
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22737,1359,1.13 [0.99-1.29],0.0609163817118676
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23149,924,1.01 [0.86-1.18],0.9266543073367268
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22543,3474,1.07 [0.99-1.16],0.0957593544098951
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Generalized epilepsy,22822,54,1.54 [0.86-2.79],0.1492080231095328
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Hemiplegia,23053,341,1.05 [0.82-1.36],0.6908865268138271
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Hydrocephalus,22573,74,0.96 [0.54-1.69],0.8764843172987782
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23191,74,1.46 [0.86-2.45],0.1574242426234328
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21330,67,0.93 [0.50-1.71],0.8123263011824882
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21336,73,1.09 [0.63-1.89],0.7575361320388555
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Memory loss,22047,143,1.32 [0.90-1.93],0.1572542946695149
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Migraine,21656,278,1.12 [0.84-1.49],0.4586637234826463
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23157,257,1.19 [0.88-1.60],0.2508273910089575
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Motor neuron disease,14279,175,0.93 [0.64-1.36],0.7126849143847077
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23071,62,0.94 [0.50-1.75],0.8357494860983393
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22494,1231,1.21 [1.06-1.39],0.0046868020602409
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Neurological diseases,21707,4376,1.10 [1.03-1.18],0.0080693045681513
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22599,328,1.17 [0.91-1.52],0.2256051154544934
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21694,431,1.32 [1.06-1.65],0.0132017515616712
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23123,355,1.44 [1.14-1.83],0.0022481559684282
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,17343,984,1.14 [0.98-1.33],0.0855877334566244
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22585,86,1.07 [0.64-1.79],0.7926506587450988
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22661,162,1.31 [0.92-1.87],0.136630336617211
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22461,236,0.94 [0.69-1.30],0.7223460958193437
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21359,96,1.33 [0.83-2.13],0.2307175775312409
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Other headache syndromes,21430,52,1.11 [0.57-2.16],0.7483308696088247
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Other neurological diseases,23086,587,0.99 [0.81-1.21],0.9543132459489426
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Other sleep disorders,21898,520,1.06 [0.86-1.30],0.5803449696941848
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Parkinson's disease,23170,684,1.02 [0.85-1.23],0.8420084542489593
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22545,46,1.32 [0.66-2.62],0.4298536832103172
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Restless leg syndrome,23204,107,0.99 [0.62-1.59],0.9766373814211484
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Sleep apnoea,22969,442,0.99 [0.79-1.25],0.9636874703624904
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22830,62,1.28 [0.70-2.31],0.4233936205400905
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23193,202,0.90 [0.64-1.28],0.5587065791759591
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21334,71,1.01 [0.57-1.79],0.9854166477798958
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23204,600,1.10 [0.90-1.33],0.3507816118825436
APOH,Beta-2-glycoprotein 1,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22236,225,1.10 [0.81-1.51],0.5348064177742422
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22555,154,1.31 [0.90-1.91],0.1524153555664684
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22750,572,1.12 [0.92-1.37],0.2712342295686339
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22948,270,1.33 [1.02-1.75],0.0358221264257254
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,21970,68,0.98 [0.54-1.77],0.9461666387509808
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,21938,36,0.83 [0.36-1.91],0.6657660611599916
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23079,73,0.95 [0.54-1.67],0.8518171687371858
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,22891,229,1.20 [0.88-1.64],0.2390108074765224
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2467,77,1.75 [1.14-2.70],0.0109339604335895
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3043,114,1.64 [1.12-2.40],0.0108228349601653
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22508,107,1.52 [0.99-2.33],0.0561277013946317
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22907,1430,1.20 [1.06-1.36],0.0039263150076046
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22785,883,0.94 [0.79-1.10],0.4353184101836468
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22203,301,0.85 [0.64-1.13],0.2717566720005781
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23131,953,1.06 [0.91-1.24],0.4521304287272161
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23198,81,1.21 [0.72-2.03],0.4767208066137504
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23058,880,1.06 [0.90-1.24],0.5181330034478466
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23161,499,1.01 [0.81-1.26],0.9086766716660054
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23083,226,1.24 [0.91-1.69],0.1705553630585851
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22001,99,0.61 [0.37-1.00],0.0488351846630338
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22007,105,0.87 [0.54-1.41],0.5774423221338891
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,21980,78,0.89 [0.51-1.56],0.6937583375270919
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23066,1013,1.06 [0.91-1.23],0.46651457431709
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22314,261,1.40 [1.06-1.85],0.0170085172776863
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22247,69,1.25 [0.71-2.19],0.4449088023537729
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22783,121,0.97 [0.62-1.50],0.8760960627708543
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23055,393,1.13 [0.89-1.44],0.3192152511164378
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22398,220,0.91 [0.65-1.27],0.574228765483912
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,22998,141,1.04 [0.69-1.58],0.8346512930044141
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22734,681,1.03 [0.85-1.24],0.7693652416177075
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22561,160,1.43 [1.00-2.04],0.0502283554358384
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20746,3255,1.09 [1.01-1.19],0.0364100708860252
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23009,347,1.09 [0.84-1.41],0.5207815717524349
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23189,190,1.07 [0.76-1.52],0.7009276028020506
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22446,544,0.90 [0.73-1.11],0.343352775179267
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22751,89,0.91 [0.54-1.53],0.72235739174848
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23189,72,1.13 [0.65-1.97],0.670369725134963
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22028,126,1.04 [0.68-1.59],0.8723992560761189
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22079,177,0.90 [0.63-1.31],0.5909791909712261
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21644,167,1.08 [0.74-1.56],0.6998551254472376
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22241,63,1.17 [0.64-2.14],0.6006062737053328
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21550,73,0.67 [0.37-1.22],0.1909820547538792
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22165,112,1.04 [0.66-1.65],0.8515779196811174
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22349,296,1.12 [0.85-1.47],0.436993653008366
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22061,159,0.99 [0.67-1.45],0.956362983306012
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21571,94,0.68 [0.40-1.15],0.1497425264209221
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21611,134,0.83 [0.54-1.28],0.4001505012205097
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20235,2744,1.12 [1.02-1.23],0.0150118863855939
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,21995,93,0.78 [0.46-1.30],0.3392343706335269
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22907,506,1.38 [1.13-1.69],0.0015590235203449
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22481,80,0.92 [0.53-1.58],0.7557475271739015
APOH,Beta-2-glycoprotein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22610,209,1.39 [1.02-1.90],0.0372751035676118
APOH,Beta-2-glycoprotein 1,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,22978,114,1.19 [0.77-1.86],0.4376292392486182
APOH,Beta-2-glycoprotein 1,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23156,140,0.84 [0.55-1.26],0.397122281016356
APOH,Beta-2-glycoprotein 1,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23067,120,1.21 [0.79-1.85],0.3889198980336622
APOH,Beta-2-glycoprotein 1,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,22930,66,1.58 [0.92-2.71],0.0953738250192632
APOH,Beta-2-glycoprotein 1,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,22933,69,1.62 [0.96-2.73],0.0722515251734658
APOH,Beta-2-glycoprotein 1,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23099,1245,1.15 [1.01-1.32],0.0349749227984948
APOH,Beta-2-glycoprotein 1,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22795,941,1.14 [0.97-1.33],0.1038537833095687
APOH,Beta-2-glycoprotein 1,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22007,153,1.32 [0.91-1.91],0.1376643859614183
APOH,Beta-2-glycoprotein 1,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,21943,89,1.38 [0.85-2.22],0.1897924577996595
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Acute pharyngitis,23010,66,2.22 [1.39-3.52],0.0007596257064803
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23131,187,1.41 [1.01-1.96],0.0416982427643593
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23007,63,1.19 [0.66-2.14],0.5713531700056216
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,All influenza,20509,157,0.98 [0.67-1.44],0.9276676532297526
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20506,154,0.95 [0.64-1.41],0.8026938180818303
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Allergic asthma (mode),14291,105,1.11 [0.70-1.78],0.6548182150820454
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Allergic rhinitis,23095,239,1.04 [0.76-1.43],0.7981014039356932
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15505,1716,1.07 [0.95-1.20],0.2730303326152915
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15881,1695,1.07 [0.95-1.20],0.2904188653332741
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22685,179,1.16 [0.82-1.65],0.389585181415486
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20456,104,1.03 [0.65-1.64],0.8879155081621997
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Bronchiectasis,19456,523,0.98 [0.79-1.21],0.8200119132807445
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",19005,72,1.27 [0.73-2.19],0.3990570009819354
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22070,3137,1.06 [0.97-1.15],0.1882610620353924
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",21973,72,1.36 [0.79-2.33],0.2723470589106196
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Chronic sinusitis,22034,133,1.25 [0.84-1.88],0.2729198177822949
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22907,1641,1.11 [0.99-1.24],0.0850940261948131
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Deviated nasal septum,21982,81,1.06 [0.62-1.80],0.842296207016032
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21044,6134,1.04 [0.98-1.11],0.1659359805469898
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22241,340,1.01 [0.78-1.32],0.9205999855798056
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Early onset COPD,21377,111,0.88 [0.56-1.40],0.5925893844163831
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Emphysema,19368,435,1.37 [1.11-1.70],0.0038712637994468
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21891,456,1.14 [0.92-1.42],0.2387316289277213
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22944,2592,1.12 [1.03-1.23],0.0126919567088404
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Interstitial lung disease,21935,500,1.12 [0.91-1.39],0.2771776955776811
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Later onset COPD,22675,1530,1.12 [1.00-1.27],0.0552667570440094
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23187,498,1.03 [0.83-1.27],0.8027957133485768
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Nasal polyp,21998,97,1.10 [0.68-1.77],0.7116778468382029
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22922,1311,1.05 [0.92-1.20],0.4546351808166268
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Other diseases of pleura,22912,2700,1.06 [0.97-1.16],0.2186768796881003
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22657,756,1.04 [0.87-1.24],0.6719640416255457
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Other pleural conditions,20281,69,0.91 [0.51-1.64],0.7586819988428153
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23082,596,1.15 [0.95-1.40],0.1392699493869338
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23073,1720,1.02 [0.91-1.15],0.7008727801692884
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Pleural effusion,21582,1370,1.11 [0.98-1.26],0.1129940870106256
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Pleural plaque,20467,255,0.96 [0.71-1.30],0.8073792303535975
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22655,2303,1.13 [1.03-1.25],0.0132918012661527
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23077,388,1.15 [0.91-1.46],0.2442517430123847
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Pneumothorax,20381,169,0.86 [0.59-1.25],0.4203018420861222
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Pollen allergy,23192,203,1.06 [0.75-1.49],0.7483910997889658
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Pulmonary oedema,22576,90,1.36 [0.86-2.17],0.1926839300344326
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Respiratory insufficiency,14257,71,1.02 [0.60-1.73],0.9407986035060611
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22898,1287,1.07 [0.94-1.22],0.3002898613304661
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22142,241,1.05 [0.77-1.44],0.7687133330116994
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Viral pneumonia,20654,302,1.05 [0.80-1.38],0.700124098333665
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22696,241,1.13 [0.84-1.52],0.4375442493018503
APOH,Beta-2-glycoprotein 1,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7383,122,0.87 [0.55-1.39],0.5629571353157288
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14681,62,2.22 [1.35-3.64],0.0017345455900802
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Acute appendicitis,23088,127,1.26 [0.83-1.90],0.2760233072192083
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Acute gastritis,16121,103,1.46 [0.95-2.26],0.0839993701472518
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Acute pancreatitis,21151,198,1.28 [0.93-1.78],0.1329382025737574
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Acute peritonitis,22705,113,1.12 [0.72-1.75],0.610300744290469
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22228,65,0.94 [0.53-1.66],0.8195286192233662
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Barrett oesophagus,16529,511,1.27 [1.04-1.56],0.0214691405773829
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21099,146,1.13 [0.76-1.66],0.5478900797219192
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22779,146,1.11 [0.76-1.64],0.585829472691743
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Cholecystitis,21175,222,1.33 [0.98-1.80],0.0658645240713239
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Cholelithiasis,22013,1060,1.02 [0.88-1.19],0.7575354598212966
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Chronic gastritis,16364,346,1.34 [1.05-1.71],0.0187960903221729
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21007,54,1.05 [0.55-2.01],0.8812465206450231
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23065,127,1.17 [0.78-1.76],0.4522830384136614
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Coeliac disease,21453,128,0.85 [0.54-1.32],0.4695927167448358
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Collagenous colitis,21444,103,1.09 [0.68-1.76],0.7222255171388953
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23086,158,1.58 [1.12-2.23],0.008610078465072
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Constipation,22918,2145,1.15 [1.04-1.28],0.0057671440052905
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Crohn disease,21431,90,1.51 [0.95-2.40],0.0784101254220326
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22850,69,1.32 [0.76-2.28],0.3279510183819865
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21423,82,1.47 [0.90-2.40],0.1196981781540099
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Dental caries,22581,188,1.41 [1.02-1.96],0.0380758288865359
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20038,2576,1.06 [0.96-1.16],0.2618233823767626
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Diseases of appendix,23119,158,1.16 [0.79-1.69],0.449471221602462
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Diseases of liver,23085,922,1.06 [0.91-1.24],0.4647058797178801
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20640,4622,1.12 [1.05-1.21],0.0011707729946647
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22870,477,1.27 [1.03-1.57],0.0260986997571719
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23110,518,1.17 [0.95-1.44],0.140385990042287
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22486,93,0.92 [0.55-1.54],0.7599352650513325
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22357,58,1.99 [1.18-3.34],0.0093210169345717
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22863,1538,1.05 [0.93-1.18],0.4641596612134221
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Diseases of tongue,22376,98,0.95 [0.58-1.55],0.8231231825002461
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22482,1529,1.08 [0.96-1.22],0.219638018363954
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18427,3808,1.17 [1.08-1.26],7.180556117199479e-05
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Duodenal ulcer,16270,252,0.86 [0.63-1.18],0.3550314980911505
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23110,205,0.76 [0.54-1.07],0.1124964553088769
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23165,27,2.16 [1.02-4.58],0.0448756629039556
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22311,148,1.15 [0.79-1.69],0.4603705701113352
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14726,107,1.85 [1.25-2.74],0.0020055402366214
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Functional dyspepsia,16582,564,1.05 [0.85-1.29],0.6613594949439484
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Gastric ulcer,16450,432,1.32 [1.06-1.63],0.0131784582644756
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18705,2687,1.07 [0.97-1.17],0.1546450029534879
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16678,660,1.17 [0.97-1.40],0.0922031649616274
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16750,8264,1.09 [1.03-1.15],0.0013397971476845
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,GI-bleeding,22603,1278,1.09 [0.95-1.24],0.223562418734375
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22438,45,0.97 [0.47-2.01],0.9423606491681892
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15614,1187,1.21 [1.06-1.39],0.0059110649824253
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22234,71,1.67 [1.03-2.73],0.0390634374030777
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Hernia,21135,3673,1.02 [0.95-1.11],0.5517551924916326
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Impacted teeth,23169,25,2.39 [1.14-5.00],0.0213516661271176
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Impaction of intestines,14695,76,0.95 [0.54-1.67],0.8712395856497414
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Inguinal hernia,18572,1110,0.97 [0.84-1.12],0.6759480329585978
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17587,125,0.93 [0.60-1.44],0.7500498960035502
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14737,118,1.73 [1.17-2.54],0.0059438257401034
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21472,147,0.90 [0.59-1.35],0.6017888563100736
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,15136,517,1.14 [0.92-1.41],0.2334182628338695
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23172,337,1.25 [0.97-1.60],0.0832059476149973
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22132,791,1.12 [0.95-1.33],0.1826572328165095
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22441,1100,1.18 [1.02-1.36],0.0237468058447044
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Oesophageal obstruction,16239,221,1.27 [0.93-1.73],0.1340802196096046
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Oesophagitis,16714,696,1.25 [1.05-1.49],0.0132754704039907
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23150,135,1.04 [0.68-1.58],0.8509754721996227
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17549,87,1.14 [0.69-1.90],0.600821874132513
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,16003,1384,1.13 [1.00-1.29],0.0559251543978162
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21313,360,1.07 [0.84-1.38],0.5793718854685397
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21098,145,1.45 [1.00-2.09],0.0514905145104641
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Other diseases of intestine,16567,1948,1.28 [1.15-1.42],4.905188171886679e-06
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Other diseases of intestines,20873,6254,1.16 [1.09-1.23],1.2249100731673283e-06
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22339,210,1.07 [0.77-1.50],0.6805655459872484
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Other diseases of liver,22923,760,1.10 [0.93-1.31],0.2619751675151958
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16794,776,1.21 [1.02-1.43],0.0250262021752832
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21170,217,1.25 [0.92-1.72],0.1561274058088211
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23031,439,1.14 [0.91-1.43],0.2698724668222417
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17121,1103,1.28 [1.11-1.47],0.0005265498651547
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22620,1295,1.08 [0.95-1.23],0.245318654461342
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22574,181,1.25 [0.88-1.76],0.2128349000938476
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16811,2192,1.21 [1.09-1.34],0.0002165093038162
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18200,2182,1.18 [1.07-1.31],0.0013204876014258
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22276,113,0.84 [0.53-1.33],0.4479916080180901
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22310,969,1.14 [0.98-1.33],0.0888427648904064
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",15069,450,1.29 [1.04-1.60],0.0225556281123323
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23161,31,2.23 [1.12-4.44],0.0220339984201125
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,15240,621,1.29 [1.07-1.55],0.0084727325169267
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21483,158,0.87 [0.59-1.28],0.4818609148152821
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23191,51,1.16 [0.60-2.24],0.6644923646682697
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22386,100,0.96 [0.59-1.57],0.8782592022076624
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Toxic colitis,21421,80,1.54 [0.94-2.50],0.0841016758094423
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16360,342,1.13 [0.87-1.46],0.3686678250593058
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Ulcerative colitis,21509,168,1.15 [0.79-1.65],0.465165066184354
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21476,135,1.13 [0.75-1.70],0.5517587415383813
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Umbilical hernia,17720,258,1.02 [0.76-1.37],0.8794163230472247
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14862,243,1.30 [0.96-1.75],0.0883516650724508
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Ventral hernia,17753,291,0.92 [0.69-1.22],0.5724319768285782
APOH,Beta-2-glycoprotein 1,Chapter XI Diseases of the digestive system,Volvulus,14713,94,1.15 [0.70-1.89],0.5697197320338565
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23097,427,1.16 [0.92-1.47],0.1959076624067349
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22837,66,0.71 [0.39-1.32],0.2812630420433686
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20641,169,0.95 [0.65-1.40],0.8109182123454471
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22569,837,1.12 [0.95-1.32],0.1699292216353129
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21878,146,1.16 [0.79-1.71],0.4435494202101399
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21110,638,1.45 [1.22-1.72],2.787454742354813e-05
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,22859,316,1.03 [0.78-1.34],0.8562533010769948
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23103,560,1.06 [0.87-1.30],0.5654156200195434
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22590,47,0.90 [0.44-1.83],0.7670508449147506
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21596,3745,1.08 [1.00-1.17],0.047493750472679
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22766,438,0.97 [0.77-1.22],0.7803190849185262
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22632,304,0.96 [0.72-1.27],0.7661797616088704
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22816,1084,1.12 [0.97-1.29],0.1170687190632455
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23183,60,1.25 [0.68-2.30],0.4656210623649826
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20529,57,1.85 [1.08-3.17],0.0253100320632781
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22391,63,1.28 [0.72-2.27],0.4042929340957256
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,22846,303,0.98 [0.74-1.29],0.8655221004610034
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21080,608,1.00 [0.82-1.22],0.9768699709741946
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20562,90,1.30 [0.80-2.12],0.293588062783477
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23114,95,1.82 [1.19-2.78],0.0054971105721763
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,21968,236,1.02 [0.75-1.39],0.914959358078219
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22997,226,0.92 [0.66-1.27],0.5975962047493741
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22639,96,1.47 [0.94-2.29],0.0888097595998267
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20549,77,0.54 [0.30-0.97],0.0407816119877598
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22591,2119,1.14 [1.03-1.26],0.0143864313461076
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21125,653,1.03 [0.86-1.25],0.72478420984558
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20566,94,1.28 [0.79-2.07],0.3190825391043446
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23111,340,0.96 [0.74-1.25],0.7515563391412385
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22619,76,1.15 [0.67-1.99],0.6063295454202514
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23049,278,0.91 [0.68-1.23],0.5482167173853516
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23129,459,1.17 [0.93-1.46],0.1779166694338921
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20598,126,0.80 [0.51-1.25],0.3189037587432203
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20811,339,1.02 [0.78-1.33],0.8861269704177136
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23118,448,1.17 [0.93-1.46],0.1842355407456225
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20813,341,1.11 [0.86-1.43],0.4195550506654749
APOH,Beta-2-glycoprotein 1,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23176,157,1.45 [1.02-2.07],0.0404286242282265
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,19341,83,0.86 [0.50-1.49],0.6011134239833598
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20433,6471,1.12 [1.05-1.19],0.0002501322563684
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19015,5053,1.13 [1.05-1.21],0.000528461113253
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19312,54,1.32 [0.71-2.45],0.373194895831211
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19252,148,1.61 [1.14-2.29],0.007215461111645
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19297,193,1.70 [1.26-2.29],0.0005122523781133
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,22937,65,0.77 [0.41-1.44],0.4137639474386048
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",19257,153,1.31 [0.90-1.91],0.1519850301309882
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15454,1492,1.15 [1.01-1.30],0.0330819346727111
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",22992,247,1.29 [0.96-1.73],0.0914963655694573
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19698,594,1.34 [1.11-1.62],0.0023362751513687
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18762,8067,1.09 [1.03-1.15],0.0014806704461199
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20640,122,0.94 [0.60-1.47],0.7857908934108317
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,19443,185,1.50 [1.09-2.06],0.012734493692045
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19760,502,0.91 [0.73-1.14],0.4263604186542801
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22264,3160,1.16 [1.07-1.26],0.000561981022608
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19571,313,1.12 [0.85-1.46],0.4199780625393191
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19409,151,1.19 [0.80-1.76],0.3980124158695786
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19371,113,0.94 [0.59-1.51],0.8009558773219505
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22451,103,1.18 [0.73-1.88],0.5001346713585823
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15985,2023,1.17 [1.05-1.30],0.0047629535197075
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14767,805,1.44 [1.23-1.68],7.500911136451309e-06
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23105,798,1.37 [1.17-1.60],0.0001052569619059
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14038,76,1.42 [0.83-2.43],0.1953427946076637
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14265,303,1.35 [1.03-1.77],0.0283448575310578
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19523,265,1.25 [0.93-1.66],0.1344396450303505
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14446,484,1.26 [1.01-1.56],0.0377237777385639
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,19186,82,2.10 [1.39-3.17],0.0004170240577328
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19796,692,1.13 [0.94-1.35],0.1822576825520609
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19426,322,1.38 [1.07-1.77],0.0137637405686027
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14415,453,1.28 [1.02-1.60],0.030231225919866
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19330,72,0.96 [0.54-1.70],0.8873730956615469
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19317,59,1.72 [1.01-2.94],0.0471479657320348
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20604,86,1.19 [0.72-1.95],0.5010275095845369
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22769,2251,1.04 [0.94-1.15],0.4457044128537047
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22093,1575,1.08 [0.96-1.22],0.203483816169865
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23028,546,1.30 [1.07-1.59],0.0091311299301061
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,17110,3148,1.18 [1.09-1.29],0.0001079930050915
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14005,43,1.20 [0.57-2.52],0.6378043010663477
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19363,105,1.32 [0.84-2.06],0.2285408381619325
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14034,72,1.30 [0.75-2.24],0.3441552342610375
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14100,138,1.55 [1.05-2.29],0.0262835152978007
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20765,247,0.82 [0.60-1.13],0.2180462435152375
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21033,515,1.15 [0.93-1.42],0.1915243238025575
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23180,115,1.16 [0.75-1.81],0.5044216445584879
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21107,2003,1.16 [1.05-1.29],0.0050881495618342
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19335,77,1.35 [0.79-2.28],0.2704439600302845
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14115,153,1.26 [0.85-1.85],0.2472923153460256
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19909,805,1.25 [1.06-1.47],0.0076345531028194
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,16158,2196,1.16 [1.05-1.28],0.0049820512633197
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22478,130,1.48 [1.00-2.19],0.0501786494974203
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23192,63,0.67 [0.36-1.27],0.2200899835069867
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19336,78,0.76 [0.43-1.34],0.3410524567760285
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20619,1361,1.09 [0.96-1.24],0.1988945018383615
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19368,110,1.75 [1.18-2.60],0.0050214677099006
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16035,2073,1.23 [1.11-1.37],7.212629541698587e-05
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20638,120,0.67 [0.42-1.06],0.0889103862789748
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19295,37,0.63 [0.27-1.48],0.2905934652012089
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,19299,195,1.42 [1.03-1.95],0.0341611819898123
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,19949,691,1.04 [0.87-1.25],0.6536158382546087
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22840,492,1.00 [0.80-1.24],0.9820047283225526
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19768,664,1.19 [1.00-1.43],0.0561512418185855
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23043,540,1.34 [1.10-1.64],0.0035277568476047
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23177,69,0.68 [0.37-1.25],0.2139115993440744
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19425,167,1.06 [0.73-1.54],0.7646371279500739
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18042,895,1.09 [0.93-1.27],0.3015130502798718
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19907,649,1.10 [0.91-1.32],0.327032152049983
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19539,281,1.10 [0.83-1.46],0.5179854385893818
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14034,72,1.60 [0.95-2.69],0.0773206643854965
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,17098,3136,1.24 [1.14-1.35],2.8394318981703174e-07
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14808,846,1.19 [1.01-1.40],0.0426366881148504
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22722,374,1.09 [0.85-1.40],0.5089740418215223
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23147,82,1.26 [0.75-2.11],0.3877033113253285
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20524,72,1.03 [0.59-1.80],0.9137040111371696
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14026,64,0.77 [0.41-1.46],0.4235417092330038
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,19210,106,0.98 [0.61-1.58],0.9401705372631648
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14516,554,1.37 [1.13-1.67],0.0015692835954379
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19598,340,1.29 [1.00-1.66],0.0512252799638038
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19390,286,1.29 [0.99-1.69],0.0635257541716844
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,19376,272,1.42 [1.08-1.87],0.0114064552512518
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,16284,68,1.65 [0.96-2.83],0.0679339275134612
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23182,74,0.70 [0.39-1.26],0.2380413617648711
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19816,558,1.19 [0.98-1.46],0.0860095678427454
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22444,96,0.62 [0.36-1.04],0.0711985051669545
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21911,2653,1.10 [1.01-1.21],0.036762819399988
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19408,150,1.18 [0.80-1.75],0.3922412983547662
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19823,719,1.15 [0.96-1.37],0.1296448517663394
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21818,274,1.34 [1.01-1.76],0.0394397204768902
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,19362,258,1.15 [0.86-1.55],0.3488103219084957
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21119,2015,1.21 [1.09-1.34],0.0003242503981308
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20417,1313,1.22 [1.08-1.39],0.0021731475991801
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19321,63,1.49 [0.85-2.60],0.1649748303876368
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22466,118,1.40 [0.92-2.13],0.1138004638971653
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19420,162,0.95 [0.64-1.40],0.7973937374514621
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,19350,92,0.93 [0.56-1.57],0.7916444386819778
APOH,Beta-2-glycoprotein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14040,78,0.91 [0.52-1.61],0.7552077574930218
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21684,2271,1.35 [1.23-1.49],5.893315215723892e-10
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9291,25,0.37 [0.14-1.02],0.0548743072356841
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11782,33,0.94 [0.38-2.27],0.8823766458128081
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22868,309,1.11 [0.85-1.45],0.4454075735072865
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22663,104,1.24 [0.79-1.94],0.3548007691306739
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21759,2346,1.65 [1.51-1.81],7.900026970076724e-29
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,22970,131,2.53 [1.86-3.43],3.1225500815254233e-09
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,22896,409,1.14 [0.90-1.43],0.2753206721019038
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Cystitis,19307,300,1.35 [1.04-1.75],0.0242586193989976
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Dialysis,19509,96,2.86 [2.02-4.04],2.956963392852437e-09
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10227,2146,1.00 [0.90-1.11],0.9722809698580308
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11882,133,0.93 [0.60-1.44],0.7581172808928313
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Endometriosis,9305,39,0.47 [0.21-1.08],0.0745954763102659
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9849,583,0.98 [0.79-1.20],0.8219231604445807
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19105,6319,1.13 [1.07-1.20],5.6572650213157445e-05
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,22936,97,2.04 [1.39-2.99],0.0002768046126543
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Hydrocele,8198,117,1.15 [0.75-1.77],0.5290356473995081
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19485,350,1.25 [0.98-1.61],0.0764952441004048
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9913,1832,0.99 [0.89-1.11],0.9026119739719344
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,11949,159,0.90 [0.61-1.35],0.6223203322307684
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8208,127,1.22 [0.80-1.84],0.3551630905896674
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,19097,90,1.30 [0.80-2.10],0.2823829465672434
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10301,1035,0.98 [0.84-1.15],0.8383714086087638
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,8140,59,0.75 [0.40-1.42],0.3789032272916918
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9306,40,0.65 [0.29-1.46],0.2963621434981361
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23189,90,1.85 [1.20-2.86],0.0052731628707317
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23192,86,1.39 [0.86-2.26],0.1824547408267217
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21986,2979,1.15 [1.06-1.26],0.0012196471390963
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19960,953,1.11 [0.95-1.30],0.1752838297219635
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11800,51,1.25 [0.65-2.41],0.5111755540389948
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23118,631,1.48 [1.25-1.77],9.558854046641986e-06
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8233,152,0.98 [0.66-1.44],0.9111900586923796
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8238,157,1.02 [0.70-1.48],0.927325770878783
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8234,153,1.11 [0.76-1.63],0.5843539237506074
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23163,86,1.40 [0.86-2.29],0.1777716597621631
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21379,2372,1.17 [1.06-1.29],0.0013183580930741
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11872,82,0.95 [0.54-1.65],0.8484474816167361
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9333,67,1.14 [0.62-2.09],0.6750689416402043
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9406,140,0.77 [0.50-1.19],0.2400066410934841
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9318,52,0.41 [0.20-0.84],0.0145576882920417
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9368,102,1.13 [0.69-1.84],0.6356820623768512
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19547,412,1.26 [1.00-1.58],0.0505145108781434
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22688,201,2.11 [1.61-2.76],5.7022762315974495e-08
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9393,127,0.97 [0.62-1.51],0.8780808417674821
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9291,25,3.31 [1.94-5.64],1.1272098058946969e-05
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9477,211,1.51 [1.10-2.08],0.0106357350083052
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9359,93,0.81 [0.48-1.38],0.4392039229632914
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9476,210,1.22 [0.87-1.71],0.2461157573467542
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,22887,48,1.62 [0.88-2.98],0.1210048223614756
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8235,154,1.43 [1.01-2.04],0.0456376615301216
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22911,3776,1.35 [1.26-1.46],1.2338032275670341e-15
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",19229,94,1.10 [0.67-1.81],0.7160110461672091
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19592,179,1.74 [1.27-2.39],0.000527782305678
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22600,41,1.27 [0.62-2.59],0.517492711346039
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Urethral stricture,19278,271,1.55 [1.19-2.01],0.0010791566262883
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22956,397,1.15 [0.91-1.45],0.2519214457143681
APOH,Beta-2-glycoprotein 1,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9301,35,1.00 [0.42-2.36],0.991145089413466
